Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Israël

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Urology|October 5, 2019
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: AcquisitionRianne R M Engels, Bas Israël, Anwar R Padhani, et al.
European Urology Open Science|July 18, 2022
Implications of the European Association of Urology Recommended Risk Assessment Algorithm for Early Prostate Cancer DetectionBas Israël, Gerjon Hannink, Jelle O Barentsz, et al.
European Urology|November 27, 2019
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: InterpretationBas Israël, Marloes van der Leest, Michiel Sedelaar, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 7, 2017
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the blockAnsje S Fortuin, Roger Brüggemann, Janine van der Linden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer PatientsMelline G M Schilham, Patrik Zamecnik, Bastiaan M Privé, et al.
European Urology|November 20, 2021
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local AnesthesiaJos Immerzeel, Bas Israël, Joyce Bomers, et al.
BJU International|August 6, 2021
Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancerBas Israël, Jos Immerzeel, Marloes van der Leest, et al.
BJUI Compass|October 20, 2025
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancerEsther H J Hamoen, Bas Israël, Marloes van der Leest, et al.
World Journal of Urology|October 30, 2024
Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomyDiederik J H Baas, Bas Israël, Joost M S de Baaij, et al.
European Urology|June 7, 2019
High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging AccessibilityMarloes van der Leest, Bas Israël, Erik Bastiaan Cornel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Urology|October 5, 2019
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: AcquisitionRianne R M Engels, Bas Israël, Anwar R Padhani, et al.
European Urology Open Science|July 18, 2022
Implications of the European Association of Urology Recommended Risk Assessment Algorithm for Early Prostate Cancer DetectionBas Israël, Gerjon Hannink, Jelle O Barentsz, et al.
European Urology|November 27, 2019
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: InterpretationBas Israël, Marloes van der Leest, Michiel Sedelaar, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 7, 2017
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the blockAnsje S Fortuin, Roger Brüggemann, Janine van der Linden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer PatientsMelline G M Schilham, Patrik Zamecnik, Bastiaan M Privé, et al.
European Urology|November 20, 2021
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local AnesthesiaJos Immerzeel, Bas Israël, Joyce Bomers, et al.
BJU International|August 6, 2021
Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancerBas Israël, Jos Immerzeel, Marloes van der Leest, et al.
BJUI Compass|October 20, 2025
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancerEsther H J Hamoen, Bas Israël, Marloes van der Leest, et al.
World Journal of Urology|October 30, 2024
Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomyDiederik J H Baas, Bas Israël, Joost M S de Baaij, et al.
European Urology|June 7, 2019
High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging AccessibilityMarloes van der Leest, Bas Israël, Erik Bastiaan Cornel, et al.
Pageof 2